InvestorsHub Logo
Followers 42
Posts 8466
Boards Moderated 2
Alias Born 11/14/2019

Re: None

Thursday, 10/13/2022 11:10:10 AM

Thursday, October 13, 2022 11:10:10 AM

Post# of 20431
That's disturbing opinion on Paxlovid because the perspective of using 3CL Proteases to combat Covid has taken a big step backwards.

I think Pfizer made a big mistake with Paxlovid when they packaged the treatment as nirmatrelvir and ritonavir. Ritonavir has been shown to have awful side effects .

Nirmatrelvir , by itself is a 3CL Ptotease inhibitor , like Tollovid.

So to take satisfaction from Pfizer's mistake is kind of counter productive.

Pfizer also made mistakes with the treatment regimen/schedule and are making adjustments on that note.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TOMDF News